Marko Repic is an Associate Director of Toxicology and Preclinical Safety in the Translational Sciences Team. Marko joined GentiBio from MC Toxicology Consulting where he provided nonclinical and toxicology consulting services to many leading companies in the cell and gene therapy space. Marko has extensive experience establishing and executing innovative non-clinical development strategies and keen interest in unraveling mechanisms behind peculiar toxicological observations. His key achievements include successful advancement of several viral gene therapy, gene editing, regenerative medicine, and immuno-oncology programs into the first-in-human studies. Marko completed his PhD and Post-Doctoral fellowship at the Institute of Molecular Biotechnology (IMBA) at the University of Vienna.
Marko Repic, PhD
Associate Director, Toxicology and Preclinical Safety